Skip to main content
OABI logo

OABI · OmniAb, Inc. · Metrics

Track OABI — free
$5.08 +0.03 (+0.59%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$740.97M
Shares
145.86M
Volume · Nov 18 1.22M Avg daily vol (3M) 1.48M

OABI metrics

78 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.08
Market cap
$740.97M

Price action

23 metrics
Price change (1W)
-0.4%
Price change (30D)
+8.3%
Price change (3M)
+21.2%
Price change (6M)
+96.9%
Price change (YTD)
+174.6%
Price change (1Y)
+215.5%
Trailing year
Price change (5Y)
-49.0%
52-week high
$5.30
52-week low
$1.36
Change from 52-week high
-4.2%
Change from 52-week low
+273.5%
Annualized volatility
75.2%
Annualized volatility (3M)
69.5%
Implied volatility (30D)
92.4%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.3
RSI (14D)
54.3
Price vs SMA 50
+6.0%
Price vs SMA 200
+74.7%
Avg volume (3M)
1.48M
Relative volume
0.8
Average dollar volume
$7.04M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
145.86M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
16.8×
reciprocal yield 5.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
18.4×
reciprocal yield 5.4%
P / book
3.0
reciprocal yield 33.6%
FCF yield
0.3%
TTM · current market cap
Buyback yield
—
P / FCF
311.3
reciprocal yield 0.3%
P / operating cash flow
277.9
reciprocal yield 0.4%
Earnings yield
-5.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
12.6×
reciprocal yield 8.0%
EV / revenue historical average (5Y)
11.7×
reciprocal yield 8.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-30

Profitability

9 metrics
Gross margin
—
Operating margin
-115.9%
Trailing 12 months
Net margin
-108.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$46.60M
Net income (TTM)
−$43.47M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
5.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
$-0.44
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.85

Growth

11 metrics
Revenue growth YoY
+78.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$40.21M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+12.7%
Year over year · more shares
Revenue CAGR (3Y)
-31.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-17.4%
Return on assets
-14.9%
Debt / equity
0.0
Current ratio
4.2
EBITDA (TTM)
−$47.22M
Free cash flow (TTM)
$2.38M
Quick ratio
4.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$22.88M
Latest balance sheet
Cash & equivalents
$22.88M
Total assets
$290.92M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.67M
Capital expenditures (TTM)
$286,000
R&D (TTM)
$42.69M
SG&A (TTM)
—
Stock compensation (TTM)
$13.16M
R&D / revenue
106.2%
Stock compensation / revenue
32.7%

Ownership (13F)

9 metrics
13F filers
174
13F filer change QoQ
+31
Institutional ownership
49.8%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
21.4%
Private-fund adviser ownership
19.9%
Active holders' share change QoQ
+23.4%
Holder tenure
8.4
Price vs estimated holder cost
+46.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.1%

Short interest

3 metrics
Short interest
5.5%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1846253 CUSIP 68218J103 13F (30d) 179 filings 167 filers Visit website Investor relations